Etoposide Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules & Injection:
Available Strengths: Injection: 20 mg/mL; Capsule: 50 mg
Reference Brands: US: VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)
Category: Oncology Cancer Care
Etoposide 20 mg/mL concentrate for infusion and 50 mg soft capsules, a topoisomerase II inhibitor used in combination chemotherapy. Offered to hospital oncology pharmacies, cancer centres, importers and tender buyers.
Manufacture or export Etoposide? List it or send an offer →
Product Description:
Etoposide is a semi-synthetic derivative of podophyllotoxin, a plant compound. It inhibits topoisomerase II, the enzyme that cuts and rejoins DNA, leaving breaks that kill dividing cancer cells. This page covers two forms. The 20 mg/mL concentrate is diluted for intravenous infusion and is used in most hospital combination chemotherapy. The 50 mg soft capsule lets selected patients take treatment by mouth, for example in palliative schedules. Oral bioavailability is roughly half, so an oral dose is about twice the intravenous one.
Etoposide is part of standard regimens for small cell lung cancer and testicular germ cell tumours, and is used in lymphomas, acute myeloid leukaemia and several childhood cancers. WHO includes it on its Model List of Essential Medicines. The concentrate is diluted, typically to no more than 0.4 mg/mL, to avoid precipitation, and infused over at least 30 minutes, since fast infusion causes hypotension. Undiluted concentrate can crack acrylic or ABS plastic devices. Myelosuppression is dose-limiting, and secondary leukaemia is a recognised late risk.
Sourcing notes. Both forms are prescription-only cytotoxic medicines, registered nationally in CTD or ACTD format from sites approved for cytotoxics. The concentrate contains solubilisers such as polysorbate 80, macrogol and ethanol, so compare excipients with the reference product. Vials are stored at room temperature away from light. Capsule storage differs between products, and some labels ask for refrigeration, so confirm before agreeing transport. Ask for a batch CoA, GMP certificate, CoPP and IVb stability. Quote form, strength, vial volume and pack count.
Also known as: etopósido (Spanish), etoposídeo (Portuguese), étoposide (French), Etoposid (German), etoposide (Italian, Vietnamese), etoposid (Turkish), etoposida (Indonesian), этопозид (Russian), إيتوبوسيد (Arabic), 依托泊苷 (Chinese), エトポシド (Japanese), 에토포시드 (Korean).
Etoposide — third party manufacturing & bulk supply
Etoposide is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Etoposide is supplied as Oral Capsules & Injection: — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Etoposide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Etoposide →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
El etopósido es un quimioterápico inhibidor de la topoisomerasa II que se utiliza, en combinación con otros antineoplásicos, principalmente en el cáncer de pulmón de células pequeñas y en el cáncer de testículo. Se usa en el ámbito hospitalario, prescrito y supervisado por oncólogos o hematólogos. PharmaTradz conecta a importadores, distribuidores y hospitales con licencia con fabricantes con certificación GMP de etopósido inyectable y en cápsulas.
O etoposídeo é um quimioterápico inibidor da topoisomerase II usado, em combinação com outros antineoplásicos, principalmente no câncer de pulmão de pequenas células e no câncer de testículo. É utilizado em ambiente hospitalar, com prescrição e acompanhamento de oncologistas ou hematologistas. A PharmaTradz conecta importadores, distribuidores e hospitais licenciados a fabricantes com certificação GMP de etoposídeo injetável e em cápsulas.
L’étoposide est un agent de chimiothérapie inhibiteur de la topo-isomérase II, utilisé en association avec d’autres anticancéreux, principalement dans le cancer du poumon à petites cellules et le cancer du testicule. Il est employé à l’hôpital, sur prescription et sous la surveillance d’oncologues ou d’hématologues. PharmaTradz met en relation les importateurs, distributeurs et hôpitaux agréés avec des fabricants certifiés BPF (GMP) d’étoposide injectable et en gélules.
Related Products
Erlotinib
Strength:
25 mg, 100 mg, 150 mg
Form: Oral Tablets
Reference Brands: Tarceva (US & EU)
View DetailsFosaprepitant Dimeglumine
Strength:
150 mg/vial
Form: Injection (IV)
Reference Brands: Emend® IV (EU & US)
View DetailsDoxorubicin
Strength:
10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials)
Form: Injection
Reference Brands: Adriamycin® (EU & US)
View DetailsNilutamide
Strength:
150 mg
Form: Tablets
Reference Brands: Nilandron (USA), Nilandron (EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit